RhumbLine Advisers’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.7K Buy
37,554
+1,326
+4% +$2.67K ﹤0.01% 3586
2025
Q4
$94.2K Sell
36,228
-3,490
-9% -$9.54K ﹤0.01% 3497
2025
Q3
$119K Sell
39,718
-373
-0.9% -$1.33K ﹤0.01% 3456
2025
Q2
$161K Buy
40,091
+3,827
+11% +$14.1K ﹤0.01% 3343
2025
Q1
$121K Sell
36,264
-1,424
-4% -$6.79K ﹤0.01% 3324
2024
Q4
$233K Buy
37,688
+3,920
+12% +$22.8K ﹤0.01% 3114
2024
Q3
$188K Buy
33,768
+5,543
+20% +$37K ﹤0.01% 3267
2024
Q2
$211K Buy
28,225
+14,404
+104% +$88.8K ﹤0.01% 3200
2024
Q1
$80.2K Sell
13,821
-259
-2% -$1.3K ﹤0.01% 3510
2023
Q4
$69.5K Hold
14,080
﹤0.01% 3554
2023
Q3
$72.1K Buy
14,080
+1,138
+9% +$6.71K ﹤0.01% 3560
2023
Q2
$87.5K Buy
+12,942
New +$76.8K ﹤0.01% 3556

Other funds holding BTMD

RhumbLine Advisers's BTMD Position: Q1 2026 in Review

RhumbLine Advisers increased its Biote Corp (BTMD) stake by 3.7% in Q1 2026, buying an estimated $2.67K and bringing the position to 37,554 shares worth $50.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3586.

RhumbLine Advisers first reported a position in BTMD in Q2 2023 and has held it in 12 quarters since. The position peaked at $233K in Q4 2024. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

  • RhumbLine Advisers held 37,554 shares of Biote Corp worth $50.7K as of Q1 2026.
  • RhumbLine Advisers bought 1,326 Biote Corp shares in Q1 2026, an estimated $2.67K.
  • Biote Corp made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #3586 holding.
  • RhumbLine Advisers first reported a position in Biote Corp in Q2 2023 and has held it in 12 quarters since.
  • RhumbLine Advisers's Biote Corp position peaked at $233K in Q4 2024.
  • 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.